EP 0831874 A1 19980401 - GENE THERAPY FOR MYOCARDIAL ISCHEMIA
Title (en)
GENE THERAPY FOR MYOCARDIAL ISCHEMIA
Title (de)
GENTHERAPIE BEI MYOCARDISCHEMIE
Title (fr)
THERAPIE GENIQUE POUR ISCHEMIE MYOCARDIQUE
Publication
Application
Priority
- US 9609858 W 19960607
- US 48112295 A 19950607
Abstract (en)
[origin: WO9640195A1] The transgene-inserted replication-deficit adenoviral vector is effectively used in in vivo gene therapy for myocardial ischemia in a protective way, by a single intracoronary injection directly conducted deeply in the lumen of the coronary arteries in an amount sufficient for transfecting all cell types in the affected region, including cardiac myocytes.
IPC 1-7
IPC 8 full level
A61K 38/17 (2006.01); A61K 48/00 (2006.01); C12N 15/861 (2006.01)
CPC (source: EP)
A61K 38/1709 (2013.01); A61K 38/177 (2013.01); A61K 48/00 (2013.01); C12N 15/86 (2013.01); C12N 2710/10343 (2013.01); C12N 2830/002 (2013.01); C12N 2830/008 (2013.01); C12N 2830/85 (2013.01)
Designated contracting state (EPC)
DE ES FR GB IT
DOCDB simple family (publication)
WO 9640195 A1 19961219; AU 6268196 A 19961230; CA 2221710 A1 19961219; EP 0831874 A1 19980401; EP 0831874 A4 20020306
DOCDB simple family (application)
US 9609858 W 19960607; AU 6268196 A 19960607; CA 2221710 A 19960607; EP 96921461 A 19960607